Purple Biotech

Purple Biotech EBITDA per Share

The EBITDA per Share of Purple Biotech (PPBT.TA) as of Oct 18, 2026 is -0.03 USD. In the previous year, EBITDA per Share was -0.09 USD — a change of -62.98% (higher).

EBITDA per Share

-0.03USD

YoY

-62.98%

Last updated:

EBITDA per Share of Purple Biotech is 2024 -0.03 USD. EBITDA per Share of Purple Biotech was 2023 -0.09 USD. It decreases by -62.98% higher compared to the previous year.

The Purple Biotech EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2017
-1.12 USD
Jan 1, 2018
-0.53 USD
Jan 1, 2019
-0.39 USD
Jan 1, 2020
-0.11 USD
Jan 1, 2021
-0.10 USD
Jan 1, 2022
-0.12 USD
Jan 1, 2023
-0.09 USD
Jan 1, 2024
-0.03 USD
The Purple Biotech EBITDA per Share history
YEAREBITDA per ShareYoY
-0.03USD-62.98%
-0.09USD-29.41%
-0.12USD+23.04%
-0.10USD-10.65%
-0.11USD-71.04%
-0.39USD-27.24%
-0.53USD-52.41%
-1.12USD+18.73%
-0.95USD-9.53%
-1.05USD-92.99%
-14.94USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Purple Biotech Stock analysis

What does Purple Biotech do? Purple Biotech Ltd., based in Rehovot, Israel, operates in the Health Care sector as a development-stage pharmaceutical company. It focuses on drug development, with key products including NT-219, a small molecule bi-specific inhibitor targeting cancer resistance pathways, and CM-24, a monoclonal antibody blocker. The company also owns Consensi, a fixed-dose combination for treating osteoarthritis pain and hypertension simultaneously. Purple Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Purple Biotech stock

EBITDA per Share of Purple Biotech is -0.03 USD in 2024.

EBITDA per Share of Purple Biotech changed from -0.09 USD to -0.03 USD, representing a -62.98% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Purple Biotech since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Purple Biotech

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Purple Biotech